Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / GENOMIC REV ETF
-
Number of holders
-
225
-
Total 13F shares, excl. options
-
22,010,714
-
Shares change
-
+668,006
-
Total reported value, excl. options
-
$611,574,253
-
Value change
-
+$21,241,825
-
Put/Call ratio
-
120%
-
Number of buys
-
93
-
Number of sells
-
-81
-
Price
-
$27.77
Significant Holders of ARK ETF TR - GENOMIC REV ETF (ARKG) as of Q3 2025
274 filings reported holding ARKG - ARK ETF TR - GENOMIC REV ETF as of Q3 2025.
ARK ETF TR - GENOMIC REV ETF (ARKG) has 225 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22,010,714 shares
.
Largest 10 shareholders include JPMORGAN CHASE & CO (3,943,913 shares), MORGAN STANLEY (2,832,170 shares), BNP PARIBAS FINANCIAL MARKETS (2,347,422 shares), GOLDMAN SACHS GROUP INC (2,159,512 shares), CITIGROUP INC (1,519,002 shares), UBS Group AG (1,121,164 shares), WELLS FARGO & COMPANY/MN (997,089 shares), STATE OF WISCONSIN INVESTMENT BOARD (890,087 shares), LPL Financial LLC (756,694 shares), and BANK OF AMERICA CORP /DE/ (385,102 shares).
This table shows the top 225 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.